Hangzhou, Zhejiang, 310003, China
NCT Number: NCT06637059
Artificially Intelligent Model for Accurate Detection of HCC
Purpose: Integrating comprehensive information on hepatocellular carcinoma (HCC) is essential to improve its early detection. The investigators aimed to develop a model with multi-modal features (MMF) using artificial intelligence (AI) approaches to enhance the performance of HCC detection.
Experimental Design: A total of 1,092 participants were enrolled from 16 centers. These participants were allocated into the training, internal validation, and external validation cohorts. Peripheral blood specimens were collected prospectively and subjected to mass cytometry analysis. Clinical and radiological data were obtained from electrical medical records. Various AI methods were employed to identify pertinent features and construct single-modal models with optimal performance. The XGBoost algorithm was utilized to amalgamate these models, integrating multi-modal information and facilitating the development of a fusion model. Model evaluation and interpretability were demonstrated using the SHapley Additive exPlanations method.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Benign liver diseases, including but not limited to, hemangiomas, hepatic cysts, focal nodular hyperplasia, and cirrhosis
Exclusion criteria
- Participants who had undergone previous treatment for HCC or benign liver diseases,
- had taken medications affecting the hematological system within 2 weeks
- those who had received a blood transfusion within 6 months
Treatment and study plan
observational study
Otherobservation alone
Primary outcomes
-
Diagnosis of liver disease through CT imaging
Time frame: 1 month
Sponsors and collaborators
Lead sponsor
Zhejiang University
Other
Registry information
Official study title
Construction of an Artificially Intelligent Model for Accurate Detection of HCC by Integrating Clinical, Radiological, and Peripheral Immunological Features
Important dates
- Study start
- 2024
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Oct 15, 2024
- Registry last updated
- Oct 15, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
HCC-MPDS Multimodal Deep Learning Prognostic Model for Resectable HCC
NCT07700082
Adenocarcinoma, Carcinoma
Hefei, Anhui, China
View Trial DetailsEstimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma
NCT07562763
Adenocarcinoma, Adjuvant Therapy
Hefei, Anhu, China
View Trial DetailsNon-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score
NCT07687758
Adenocarcinoma, Blood-Borne Infections
Bangkok, Thailand
View Trial DetailsHepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
NCT02562755
Adenocarcinoma, Carcinoma
Birmingham, Alabama, United States
View Trial Details